Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Priming of cancer cells with low dose naltrexone

Priming of cancer cells with low dose naltrexone

US Patent 11065245 · Granted Jul 20, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer treatment2025
Combination of cannabinoids in the treatment of leukemia2024
Combination of cannabinoids in the treatment of leukemia2024
Priming of cancer cells with low dose naltrexone2024
Priming of cancer cells with low dose naltrexone2024
Autoimmune therapy2024
Autoimmune therapy2024
Assay to identify anti-cancer agents2024
Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of 2023
Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of 2023
Agent that increases the expression of the opioid kappa 1 for the treatment of c2022
Combination for use in the treatment of lung cancer2022